Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,641 | -1,998 | -11,956 | -9,297 | -5,938 |
| Depreciation Amortization | 1 | 1 | 4 | 3 | 2 |
| Accounts payable and accrued liabilities | -1,284 | -1,507 | 663 | 391 | 371 |
| Other Working Capital | -1,582 | -1,732 | 925 | 1,317 | 750 |
| Other Operating Activity | 1,375 | 1,551 | 178 | 371 | -87 |
| Operating Cash Flow | $-5,131 | $-3,685 | $-10,186 | $-7,215 | $-4,902 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -3 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $-3 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,214 | 6,819 | 15,560 | 7,560 | 5,941 |
| Other Financing Activity | -365 | -315 | -2,170 | -1,318 | -945 |
| Financing Cash Flow | $7,849 | $6,504 | $13,390 | $6,242 | $4,996 |
| Beginning Cash Position | 8,229 | 8,229 | 5,028 | 5,028 | 5,028 |
| End Cash Position | 10,947 | 11,048 | 8,229 | 4,055 | 5,122 |
| Net Cash Flow | $2,718 | $2,819 | $3,201 | $-973 | $94 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,131 | -3,685 | -10,186 | -7,215 | -4,902 |
| Capital Expenditure | N/A | N/A | -3 | N/A | N/A |
| Free Cash Flow | -5,131 | -3,685 | -10,189 | -7,215 | -4,902 |